Ticker Scorecard - KYMR Basics Company: Kymera Therapeutics, Inc. IPO Date: August 21, 2020 Sector: Healthcare Industry: Biotech Market Cap: $2.51B Activated in VL: True Average Daily Range Avg Daily Range: $1.23 | 3.25% Avg Daily Range (30 D): $1.17 | 2.84% Avg Daily Range (90 D): $1.15 | 2.59% Institutional Daily Volume Avg Daily Volume: .41M Avg Daily Volume (30 D): .37M Avg Daily Volume (90 D): .34M Trade Size Avg Trade Size (Sh.): 56 Avg Trade Size (Sh.) (30 D): 47 Avg Trade Size (Sh.) (90 D): 45 Institutional Trades Total Inst.Trades: 1,889 Avg Inst. Trade: $2.41M Avg Inst. Trade (30 D): $2.76M Avg Inst. Trade (90 D): $2.71M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.11M Avg Closing Trade (30 D): $3.54M Avg Closing Trade (90 D): $3.32M Avg Closing Volume: 90.65K     News Jan 30, 2025 @ 12:00 PM Kymera Therapeutics to Participate in Upcoming Feb... Source: N/A Nov 26, 2024 @ 12:00 PM Kymera Therapeutics to Participate in Upcoming Dec... Source: N/A Aug 20, 2024 @ 2:45 AM Kymera Therapeutics Announces Pricing of $225 Mill... Source: N/A Jul 9, 2024 @ 9:09 PM Kymera Therapeutics soars as Sanofi expands phase ... Source: Oliver Gray Jul 9, 2024 @ 5:30 PM Why Kymera Therapeutics Stock Is Soaring Today - T... Source: Keith Speights Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.34 $-.82 $-.58 Diluted EPS $-2.34 $-.82 $-.58 Revenue $ 87.56M $ 3.74M $ 25.65M Gross Profit $ $ $ Net Income / Loss $ -167.47M $ -62.49M $ -42.06M Operating Income / Loss $ -200.19M $ -72.12M $ -50.93M Cost of Revenue $ $ $ Net Cash Flow $ 29.66M $ 43.05M $ -25.88M PE Ratio